Cerebral muscarinic acetylcholinergic receptor measurement in Alzheimer’s disease patients on11C-N-methyl-4-piperidyl benzilate — Comparison with cerebral blood flow and cerebral glucose metabolism—
- 1 February 1998
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Nuclear Medicine
- Vol. 12 (1), 35-42
- https://doi.org/10.1007/bf03165414
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Synthesis, in vivo biodistribution and dosimetry of [11C]N-Methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonistNuclear Medicine and Biology, 1995
- Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomographyNeuroscience Letters, 1993
- The Retention of [99mTc]-d,l-HM-PAO in the Human Brain after Intracarotid Bolus Injection: A Kinetic AnalysisJournal of Cerebral Blood Flow & Metabolism, 1988
- Muscarinic Acetylcholine Receptors in Alzheimer's DiseaseJAMA, 1985
- Loss of M2 Muscarine Receptors in the Cerebral Cortex in Alzheimer's Disease and Experimental Cholinergic DenervationScience, 1985
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- A Method for Attenuation Correction in Radionuclide Computed TomographyIEEE Transactions on Nuclear Science, 1978
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975